Trialhub

What Trialhub does

Trialhub, operating as FindMeCure Ltd., is a UK-based data intelligence platform focused on clinical trial planning, feasibility, and country strategy. Founded in 2019, the company serves pharmaceutical sponsors, contract research organizations (CROs), and biotech companies by aggregating clinical, regulatory, and patient-level data to inform trial design, site selection, and reimbursement strategy. Its stated customer base includes top-tier pharma such as Boehringer Ingelheim and major CROs including Syneos Health, Premier Research, Bionical Emas, Avance Clinical, Indegene, Advanced Clinical, and PRC Clinical, among others.

The core platform combines structured data from over 80,000 sources — including 2 million PubMed articles and more than 2,000 clinical guidelines — with proprietary AI/ML capabilities delivered through TrialHub IQ. TrialHub IQ, initially launched in June 2023 and substantially enhanced in November 2024 with AI-powered insight extraction co-developed with Boehringer Ingelheim, uses NLP, embedding architectures, and vector similarity to perform multimodal analysis of clinical text and structured data for protocol feasibility, competitive intelligence, and knowledge retrieval. A Reimbursed Drugs module, launched in November 2021, extends coverage into payer and reimbursement intelligence for trial country selection.

Trialhub operates an enterprise SaaS business model with quote-based annual subscriptions, supplemented by dedicated workspace deployments for major sponsors and an emerging API and data licensing offering. Go-to-market is primarily direct enterprise sales to pharma R&D operations and CRO feasibility teams, layered with strategic channel partnerships — including Indegene for Phase 3 acceleration (January 2024), EUPATI/1MEDs for patient empowerment, and regional CRO partners such as AICROS — to extend reach without proportional sales headcount. The company is privately held and does not publicly disclose revenue, funding, or valuation; headcount is reported in the 11–50 range.

Name

Trialhub

Legal name

FindMeCure Ltd.

Website

https://trialhub.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

Trialhub (FindMeCure Ltd.) is a UK-based AI-powered data intelligence platform for clinical trial planning and feasibility, serving pharma sponsors and CROs. Its TrialHub IQ product uses NLP and embeddings over 80,000+ clinical and regulatory sources to support protocol design and country strategy.

Ownership category

akta.pro rank

Product category

Clinical Trial Intelligence Software

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Prepackaged Software (7372), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials) (HLAAANAI)

akta.pro secondary industries

Clinical Trial Analytics, Risk-Based Monitoring (RBM) & Quality Management (HLACAOAI), Site & Investigator Platforms (Site Payments, Feasibility, Activation) (HLACAOAJ)

Keywords

• Clinical trial planning
• Clinical trial intelligence
• Patient feasibility analysis
• Country and site feasibility
• Standard of care tracking

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Platform Subscription - SaaS: TrialHub operates as a SaaS platform with subscription-based access to Products and Services. Fees are determined by selected Package of Products and Services with Package Terms typically one year. Access to the Platform and Products is granted through Purchase Order Forms with tiered packages. The platform also offers free trial periods for certain functionalities.
2. Professional Services: Professional services provided by the Company to the Customer in consideration of Fees, as included in the Purchase Order Form. This includes expert analyst support, dedicated platform development for specific partners, and training.
3. API and Data Licensing: API or data licensing products are offered under separate Data License and API Agreement, representing an additional revenue stream for specialized data access.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

TrialHub is an AI-powered data intelligence SaaS platform that helps pharmaceutical, biotech, and CRO organizations plan and optimize clinical trials. Its core product, TrialHub IQ, uses NLP, ML, and embedding/vector similarity techniques to query and synthesize data aggregated from 80,000+ sources — including clinical trial registries, 2 million PubMed articles, and 2,000+ medical guidelines — to support patient feasibility, country and site feasibility, standard of care analysis, reimbursement intelligence, and trial performance benchmarking.

Product overview

TrialHub is a unified clinical trial planning platform powered by NLP and AI technology. The core product is TrialHub IQ, an intelligent query system that provides real-time insights on patients, sites, competition, and regulations. The platform operates on a modular architecture combining the central AI engine with specialized modules including the Standard of Care (SoC) module for reimbursement and treatment landscape analysis, the Reimbursed Drugs module for drug reimbursement intelligence, Patient Feasibility for recruitment potential analysis, Country and Site Feasibility for site selection, Trial Performance for benchmarking planned vs. actual outcomes, and Decentralized Clinical Trials support for virtual trial planning. Expert support is available as an add-on service. The platform aggregates data from 80,000+ sources including clinical trial registries and medical literature.

Differentiator

Problem solved

Functional benefit

Products and services

• TrialHub Platform (TrialHub IQ) AI-powered data intelligence SaaS platform for clinical trial planning, anchored by TrialHub IQ, a natural-language query engine built on embedding architecture, vector similarity, NLP, and ML that synthesizes information from 80,000+ sources including clinical trial registries, PubMed, and medical guidelines. Sold as annual Packages to pharma, biotech, and CRO organizations via Purchase Order Forms.
• Reimbursed Drugs Module Module allowing search for reimbursed drugs by drug name, indication, or country, providing country reimbursement systems information, drug details, level of reimbursement, and prices in local currency; supports clinical trial feasibility and market access research for pharma, biotech, and CRO customers.
• Ask the Analyst — Expert Support Service Human expert support service comprising medical experts, analysts, and data scientists who provide personalized assistance, custom analysis, and advisory services for clinical trial planning; sold as an add-on Professional Services offering under the Purchase Order Form.
• TrialHub API and Data Licensing Programmatic API and data licensing product that lets enterprise customers pull TrialHub data into their internal tools; governed by a separate Data License and API Agreement and not included in standard Platform access rights.

Quantifiable outcome

• 45% of clinical trial amendments are avoidable with proper feasibility planning (Tufts CSDD study)
• +6 more outcomes

Named customers11 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature6 records

Partnerships

Twelve partnerships are on record, tiered core and strategic.

• Boehringer IngelheimcoreStrategic or Co-development Partner · 14 November 2024TrialHub developed a dedicated AI-powered workspace for Boehringer Ingelheim's Scleroderma clinical trial planning. The partnership involved seamless access and integration of Boehringer Ingelheim's internal datasets with TrialHub's external data repositories. TrialHub IQ enabled rapid translation of expansive datasets into actionable patient-centric insights, reducing analysis time from 3-6 months to several hours.
• TrialbeestrategicStrategic or Co-development Partner · 4 June 2024Co-hosted webinar on leveraging patient data, AI, and modern technology to improve enrollment outcomes. Trialbee brings 20+ years of software and leadership experience in life sciences.
• BiomapascoreStrategic or Co-development Partner · 16 May 2024Partnership to drive innovations in clinical trial management. Biomapas, a mid-sized CRO, uses TrialHub for real-time feasibility checks during client meetings and oncology trial strategy development.
• 1MEDs (EUPATI)strategicGTM or Marketing Partner · 7 May 2024Partnership supporting EUPATI's educational program through patient empowerment in clinical trials. TrialHub's platform supports patient education initiatives.
• Advanced ClinicalstrategicGTM or Marketing Partner · 20 March 2024Collaboration on patient inclusion advocacy through EUPATI partnership. Advanced Clinical uses TrialHub for SoC data and reimbursement monitoring, reducing country feasibility time by 25%.
• AcromioncoreStrategic or Co-development Partner · 4 March 2024Strategic alliance to innovate clinical research. Acromion partners with TrialHub for feasibility and trial planning capabilities.
• AICROSstrategicGTM or Marketing Partner · 27 February 2024AICROS partners with TrialHub to accelerate study feasibility. AICROS uses TrialHub for feasibility assessments and internal training as a stellar example of customer care.
• Premier ResearchstrategicGTM or Marketing Partner · 31 January 2024Collaboration to shape patient-centric healthcare and educate patients about clinical research. Premier Research uses TrialHub for feasibility assessments and strategy development.
• IndegenecoreStrategic or Co-development Partner · 11 January 2024TrialHub's data intelligence combined with Indegene's digital-first approach to accelerate patient recruitment for a Phase 3 drug trial of a global biopharma.
• ClinsciencecoreStrategic or Co-development Partner · 16 November 2022Global SMART CRO with presence in Europe, US, and India uses TrialHub for Phase IIb acute ischemic stroke study planning. TrialHub's algorithm provided site selection support and expert analysis for country and site assessment.
• OPIS ResearchcoreStrategic or Co-development Partner · 7 June 2022Data-driven clinical CRO leverages medical and scientific experience together with TrialHub's advanced analytics to support clinical trial sponsors.
• August ResearchcoreStrategic or Co-development Partner · 13 January 2022European CRO partnering with TrialHub to innovate the feasibility process and provide better data-backed proposals to sponsors.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Flatiron Health: Flatiron Health (a Roche company) provides real-world oncology data, EHR-derived cohorts, and clinical trial matching services. Its oncology RWD and patient matching capabilities intersect with TrialHub's patient feasibility and country/site selection offerings in oncology indications.
• Health Catalyst: Health Catalyst is a healthcare data and analytics platform serving providers and life sciences organizations, with growing life sciences analytics offerings. Its data aggregation and analytics capabilities are thematically comparable to TrialHub's data intelligence platform approach for clinical research use cases.
• Castor: Castor is an eClinical platform offering EDC, ePRO, eConsent, and decentralized trial tools for biotech, pharma, and CROs. As an emerging player with strong self-service and biotech positioning, it competes for the same mid-market and enterprise trial planning and execution budgets as TrialHub.

Direct peers

• Signant Health: Signant Health provides clinical trial technology including eCOA, eConsent, patient engagement, and trial supply management, with deep CRO and pharma relationships. Its focus on clinical operations technology and patient-centric trial execution makes it a direct peer for parts of TrialHub's portfolio, particularly DCT support and patient feasibility.
• Clario: Clario (formed from the merger of Bioclinica and ERT) delivers clinical trial endpoint technologies, eCOA, imaging, and decentralized trial solutions. Its breadth in clinical operations technology and patient-centric data overlaps with TrialHub's feasibility, patient pathways, and decentralized trial support offerings.
• Cytel: Cytel provides statistical software, clinical trial design optimization, and real-world evidence analytics for biopharma, with a focus on adaptive trials and feasibility. Its trial design and analytics offerings overlap directly with TrialHub's protocol design and trial performance benchmarking modules.

Broad incumbents

• IQVIA: IQVIA is the largest CRO and life sciences technology provider globally, offering EDC, clinical trial analytics, feasibility, and site/patient recruitment tools bundled with its R&D Solutions business. It is a broad incumbent with overlapping capabilities to TrialHub across feasibility and trial planning, and an established enterprise sales motion into the same pharma and CRO buyers.
• Veeva Systems: Veeva's Vault Clinical and Vault CDB applications support clinical operations, study design, and trial data management across most large pharma. As a broad life sciences cloud incumbent with deep enterprise relationships, it competes for the same clinical planning budget that TrialHub targets.
• Medidata Solutions (Dassault Systèmes): Medidata provides the Rave clinical cloud — EDC, eCOA, RTSM, and operational analytics — used by most large pharma and CROs. Its broader platform addresses trial design, feasibility, and operational benchmarking, making it a direct broad incumbent comparable to TrialHub in trial planning and analytics workflows.
• Oracle Clinical One: Oracle Clinical One is a unified clinical trial platform offering EDC, RTSM, patient engagement, and analytics for pharma and CROs. As a broad incumbent from a major enterprise software vendor, it targets the same trial operations and planning use cases as TrialHub and bundles adjacent capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks1 record

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/trialhub

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Trialhub